Hamilton Lane Incorporated (NASDAQ:HLNE) Given Consensus Recommendation of "Reduce" by Analysts

Shares of Hamilton Lane Incorporated (NASDAQ:HLNE - Get Free Report) have earned an average rating of "Reduce" from the seven research firms that are presently covering the firm, Marketbeat Ratings reports. One equities research analyst has rated the stock with a sell recommendation and six have assigned a hold recommendation to the company. The average twelve-month target price among brokerages that have issued a report on the stock in the last year is $164.29.

A number of research analysts have recently issued reports on the company. Wells Fargo & Company reduced their price objective on Hamilton Lane from $166.00 to $161.00 and set an "equal weight" rating on the stock in a research note on Friday, May 30th. Wall Street Zen lowered Hamilton Lane from a "hold" rating to a "sell" rating in a research report on Friday, June 6th. Keefe, Bruyette & Woods decreased their price target on Hamilton Lane from $162.00 to $155.00 and set a "market perform" rating on the stock in a research note on Monday, June 2nd. Oppenheimer lowered Hamilton Lane from an "outperform" rating to a "market perform" rating in a research note on Thursday, May 15th. Finally, JPMorgan Chase & Co. cut their target price on shares of Hamilton Lane from $176.00 to $167.00 and set a "neutral" rating on the stock in a report on Tuesday, April 29th.

Hamilton Lane Stock Down 5.1%

Shares of HLNE opened at $138.95 on Friday. Hamilton Lane has a 1 year low of $114.85 and a 1 year high of $203.72. The company has a debt-to-equity ratio of 0.34, a current ratio of 4.19 and a quick ratio of 4.19. The stock has a 50 day simple moving average of $153.55 and a two-hundred day simple moving average of $155.11. The firm has a market cap of $7.44 billion, a P/E ratio of 25.64 and a beta of 1.25.

Hamilton Lane (NASDAQ:HLNE - Get Free Report) last announced its quarterly earnings data on Thursday, May 29th. The company reported $1.21 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.20 by $0.01. The company had revenue of $197.97 million during the quarter, compared to analysts' expectations of $165.49 million. Hamilton Lane had a net margin of 31.12% and a return on equity of 36.69%. The firm's revenue was up 12.1% on a year-over-year basis. During the same quarter in the prior year, the company earned $1.38 EPS. On average, analysts forecast that Hamilton Lane will post 4.97 earnings per share for the current fiscal year.

Hamilton Lane Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, July 7th. Stockholders of record on Friday, June 20th will be given a $0.54 dividend. This is a positive change from Hamilton Lane's previous quarterly dividend of $0.49. This represents a $2.16 dividend on an annualized basis and a dividend yield of 1.55%. The ex-dividend date of this dividend is Friday, June 20th. Hamilton Lane's dividend payout ratio (DPR) is currently 40.07%.

Institutional Investors Weigh In On Hamilton Lane

A number of large investors have recently made changes to their positions in HLNE. Vanguard Group Inc. lifted its stake in Hamilton Lane by 28.4% in the fourth quarter. Vanguard Group Inc. now owns 3,901,933 shares of the company's stock worth $577,681,000 after acquiring an additional 863,326 shares during the period. Kayne Anderson Rudnick Investment Management LLC bought a new position in Hamilton Lane in the 1st quarter worth $432,772,000. Invesco Ltd. raised its holdings in Hamilton Lane by 25.3% in the 4th quarter. Invesco Ltd. now owns 1,923,253 shares of the company's stock worth $284,738,000 after purchasing an additional 388,019 shares in the last quarter. Wellington Management Group LLP lifted its position in shares of Hamilton Lane by 5.5% in the 1st quarter. Wellington Management Group LLP now owns 1,701,963 shares of the company's stock worth $253,031,000 after purchasing an additional 88,100 shares during the period. Finally, Price T Rowe Associates Inc. MD boosted its stake in shares of Hamilton Lane by 5.9% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 1,368,373 shares of the company's stock valued at $203,437,000 after purchasing an additional 76,107 shares in the last quarter. 97.40% of the stock is currently owned by institutional investors.

About Hamilton Lane

Hamilton Lane Incorporated is a private equity firm specializing in early venture, emerging growth, turnaround, middle market, mature, mid-venture, bridge, buyout, distressed/vulture, loan, mezzanine in growth capital companies. It prefers to invest in energy, industrials, consumer discretionary, health care, real estate, information technology, utilities, and consumer services.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.